Recommendations for antibiotic prophylaxis before ERCP: Can we come to workable conclusions after review of the literature?

Acta Clinica Belgica

Volumn 61, Issue 1, 2006, Pages 10-18

  Ceyssens, Clara ^a   Frans, J M E ^a   Christiaens, P S M ^a   Van Steenbergen, W ^b   Peetermans, W E ^b  

^a IMELDA HOSPITAL   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Antibiotic prophylaxis; Cholangiopancreaticography; Cholangitis; Endocarditis; Endoscopic retrograde

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFADROXIL; CEFALEXIN; CEFAZOLIN; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; METRONIDAZOLE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; UREIDOPENICILLIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL ENDOCARDITIS; BILE DUCT OBSTRUCTION; BLOOD VESSEL GRAFT; CHOLANGITIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HIGH RISK PATIENT; HUMAN; INFECTION; PANCREAS PSEUDOCYST; PRACTICE GUIDELINE; REVIEW; SEPSIS;

ANTIBIOTIC PROPHYLAXIS; BELGIUM; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; MALE; PRACTICE GUIDELINES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 33645575988     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Bilbao MK, Dotter CT, Lee TG, Katon RM. Complications of endoscopic retrograde cholangiopancreatography (ERCP). A study of 10 000 cases. Gastroenterology 1976;70(3):314-20.
2. Devière J, Motte S, Dumonceau JM, Serruys E, Thys JP, Cremer M. Septicemia after endoscopic retrograde cholangiopancreatography. Endoscopy 1990;22(2):72-5.
3. Freeman M, Nelson D, Sherman S et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996;335(13):909-18.
4. Alveyn CG. Antimicrobial prophylaxis during biliary endoscopic procedures. J Antimicrob Chemother 1993;31 suppl B:101-5.
5. Nelson DB. Infectious disease complications of GI endoscopy: Part I, endogenous infections. Gastrointest Endosc 2003;57:546-56.
6. Subhani JM, Kibbler C, Dooley JS. Antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP). Aliment Pharmacol Ther 1999;13:103-16.
7. Pitt HA, Postier RG, Cameron JL. Biliary Bacteria: significance and alterations after antibiotic therapy. Arch Surg 1982;117(4):445-9.
8. Maluenda F, Csendes A, Burdiles P, Diaz J. Bacteriological study of choledochal bile in patients with common bile duct stones, with or without acute suppurative cholangitis. Hepatogastroenterology 1989;36(3):132-5.
9. Leung JW, Ling TK, Chan RC et al. Antibiotics, biliary sepsis, and bile duct stones. Gastrointest Endosc 1994;40(6):716-21.
10. Sung JJ, Lyon DJ, Suen R et al. Intravenous ciprofloxacin as treatment for patients with acute suppurative cholangitis: a randomized, controlled clinical trial. J Antimicrob chemother 1995;35(6):885-64.
11. Meijer WS, Schmitz PI. Prophylactic use of cefuroxime in biliary tract surgery: randomized controlled trial of single versus multiple dose in high-risk patients. Galant Trial Study Group. Br J Surg 1993;80(7):917-21.
12. Van Steenbergen W, Rigauts H, Ponette E, Peetermans W, Pelemans W, Fevery J. Percutaneous transhepatic cholecystectomy for acute complicated calculous cholecystitis in elderly patients. J Am Geriatr Soc 1993;41(2):157-62.
13. Thompson J, Bennion RS, Pitt HA. An analysis of infectious failures in acute cholangitis. HPB Surg 1994;8(2):139-45.
14. Cryan EM, Falkiner FR, Mulvihill TE, Keane CT, Keeling PW. Pseudomonas aeruginosa cross-infection following endoscopic retrograde cholangiopancreatography. J Hosp Infect 1984;5:371-6.
15. Bass DH, Oliver S, Bornman PC. Pseudomonas septicaemia after endoscopic retrograde cholangiopancreatgraphy-an unresolved problem. S Afr Med J 1990;77:509-11.
16. Helm EB, Bauernfeind A, Frech K, Hagenmuller F. Pseudomonas septicaemia after endoscopic interventions on the bile duct system. Dtsch Med Wochenschr 1984;109:697-701.
17. Doherty DE, Falko JM, Lefkovitz N, Rogers J, Fromkes J. Pseudomonas aeruginosa sepsis following retrograde cholangiopancreatography (ERCP). Dig Dis Sci 1982;27:169-70.
18. Siegman-Igra Y, Isakov A, Inbar G, Cahaner J. Pseudomonas aeruginosa septicimia following endoscopic retrograde cholangiopancreatography with a contaminated endoscope. Scand J Infect Dis 1987;19:527-30.
19. Lam SK, Tsui JK, Chan PK, Wong KP, Ong GB. How often does bacteraemia occur following endoscopic retrograde cholangiopancreatography (ERCP)? Endoscopy 1977;9:231-4.
20. Parker H, Geenen JE, Bjork JT, Stewart ET. A prospective analysis of fever and bacteremia following ERCP. Gastrointest Endosc 1979;25(3):102-3.
21. Siegel JH, Berger SA, Sable RA, Ho R, Rosenthal WS. Low incidence of bacteremia following endoscopic retrograde cholangiopancreatography (ERCP). Am J Gastroenterol 1979;71:465-8.
22. Low DE, Micflikier AB, Kennedy JK, Stiver HG. Infectious complications of endoscopic retrograde cholangiopancreatography: A prospective assessment. Arch Intern Med 1980;140(8):1076-7.
23. Dutta S, Cox M, Williams RB, Eisenstat TE, Standiford HC. Prospective evaluation of the risk of bacteremia and the role of antibiotics in ERCP. J Clin Gastroenterol 1983;5:325-9.
24. Kullman E, Borch K, Lindstrom E, Ansehn S, Ihse I, Anderberg B. Bacteremia following diagnostic and therapeutic ERCP. Gastrointest Endosc 1992;38:444-9.
25. Low DE, Shoenut JP, Kennedy JK, Harding GK, Den Boer B, Micflikier AB. Risk of bacteremia with endoscopic sphincterotomy. Canadian J Surg 1987;30:421-3.
26. Sauter G, Grabein B, Huber G, Mannes GA, Ruckdeschel G, Sauerbruch T. Antibiotic prophylaxis of infectious complications with endoscopic retrograde cholangiopancreatography. A randomized controlled study. Endoscopy 1990;22:164-7.
27. Niederau C, Pohlmann U, Lubke H, Thomas L. Prophylactic antibiotic treatment in therapeutic or complicated diagnostic ERCP: results of a randomized controlled clinical trial. Gastrointest Endosc 1994;40(5):533-7.
28. Byl B, Devière J, Struelens MJ et al. Antibiotic prophylaxis for infectious complications after therapeutic retrograde cholangiopancreatography: a randomized, double-blind, placebo controlled study. Clin Infect Dis 1995;20(5):1236-40.
29. Dajani AS, Taubert KA, Wilson W et al. Prevention of bacterial endocarditis. Recommendations by the American heart association. JAMA 1997;277(22):1794-801.
30. Hirota WK, Petersen K, Baron TH et al. Guidelines for antibiotic prophylaxis for GI endoscopy. American Society for Gastrointestinal Endoscopy. Gastrointest Endosc 2003;58(4):475-82.
31. Rey JR, Budzynska A, Axon A, Kruse A, Nowak A. Antibiotic prophylaxis for gastrointestinal endoscopy. European Society of gastrointestinal Endoscopy. Endoscopy 1998;30:318-24.
32. Mani V, Cartwright K, Dooley J, Swarbrick E, Fairclough P, Oakley C. Antibiotic prophylaxis in gastrointestinal endoscopy: a report by a Working Party for the Britisch Society of Gastroenterology Endoscopy Committee. Endoscopy 1997;29(2):114-9.
33. Cowen AE, Rayner T, Jones D, King B. Infection control in endoscopy. Gastroenterological Society of Australia and Gastroenterological nurses Society of Australia; 1999.
34. Shulman ST, Amren DP, Bisno AL et al. Prevention of bacterial endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council of Cardiovascular Disease in the Young. Circulation 1984;70:1123A-7A.
35. Kaye D. Prophylaxis for infective endocarditis: an update. Ann Intern Med 1986;104(3):419-23.
36. Meyer GW. Prophylaxis of infective endocarditis during gastrointestinal procedures; report of a survey. Gastrointest Endosc 1979;25(1):1-2.
37. Infection control during gastrointestinal endoscopy: guidelines for the clinical application. Gastrointest Endosc 1988;34:375-405.
38. Zuckerman GR, O'Brien J, Halsted R. Antibiotic prophylaxis in patients with infectious risk factors undergoing gastrointestinal endoscopic procedures. Gastrointest Endosc 1994;40(5):538-43.
39. Meyer GW. Antibiotic prophylaxis for gastrointest procedures: who needs it? Gastrointest Endosc 1994;40(5):645-6.
40. Durack DT. Prevention of infective endocarditis. N Engl J Med 1995;332(1):38-44.
41. Bianco JA, Pepe MS, Higano C, Applebaum FR, McDonald GB, Singer JW. Prevalence of clinically relevant bacteremia after upper gastrointestinal endoscopy in bone marrow transplant recipients. Am J Med 1990;89(2):134-136.
42. Malone J, Moore W, Campagna G, Bean B. Bacteremic infectability of vascular grafts: the influence of pseudointimal integrity and duration of graft function. Surgery 1975;78(2):211-216.
43. Moore WS, Rosson CT, Hall AD. Effect of prophylactic antibiotics in preventing bacteremic infection of vascular prostheses. Surgery 1971;69:825-8.
44. Lai EC, Lo CM, Choi TK, Cheng WK, Fan ST, Wong J. Urgent biliary decompression after endoscopic retrograde cholangiopancreatography. Am J Surg 1989;157:121-5.
45. Khardori N, Wong E, Carrasco CH, Wallace S, Patt Y, Bodey GP. Infections associated with biliary drainage procedures in patients with cancer. Rev Infect Dis 1991;13(4);587-91.
46. Motte S, Deviere J, Dumonceau JM, Serruys E, Thys JP, Cremer M. Risk factors for septicaemia following endoscopic biliary stenting. Gastroenterology 1991;101:137-81.
47. Brandes JW, Scheffer B, Lorenz-Meyer H, Korst HA, Littmann KP. ERCP: complications and prophylaxis: a controlled study. Endoscopy 1981;13(1):27-30.
48. Finkelstein R, Yassin K, Suissa A, Lavy A, Eidelman S. Failure of cefonicid prophylaxis for infectious complications related to endoscopic retrograde cholangiopancreatography. Clin Infect Dis 1996;23(2):378-9.
49. Van den Hazel SJ, Speelman P, Dankert J, Huibregtse K, Tytgat GN, van Leeuwen DJ. Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial. Ann Intern Med 1996;125:442-7.
50. Alveyn CG, Robertson DA, Wright R, Lowes JA, Tillotson G. Prevention of sepsis following endoscopic retrograde cholangiopancreatography. J Hosp Infection 1991;19 suppl C:65-70.
51. Smith BC, Alqamish JR, Watson KJ, Shaw RG, Andrew JH, Desmond PV. Preventing endoscopic retrograde cholangiopancreatography related sepsis: a randomized controlled trial comparing two antibiotics regimens. J Gastroenterol Hepatol 1996;11:938-41.
52. Mehal WZ, Culshaw KD, Tillotson GS, Chapman RW. Antibioic prophylaxis for ERCP; a randomized clinical trial comparing ciprofloxacin and cefuroxime in 200 patients at high risk of cholangitis. Eur J Gastroenterol Hepatol 1995;7:841-5.
53. Siegman-Igra Y, Spinrad S, Rattan J. Septic complications following endoscopic retrograde cholangiopancreatography: the experience in Tel Aviv Medical Centre. J Hosp Infect 1988;12(1):7-12.
54. Harris A, Chan AC, Torres-Viera C, Hammett R, Carr-Locke D. Meta-analysis of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography (ERCP). Endoscopy 1999;31(9):718-24.
55. Thompson BF, Arguedas MR, Wilcox CM. Antibiotic prophylaxis prior to endoscopic retrograde cholangiopancreatography in patients with obstructive jaundice: is it worth the cost? Aliment Pharmacol Ther 2002;165(4):727-34.
56. Gerecht WB, Henry NK, Hoffman WW et al. Prospective randomized comparison of mezlocillin therapy alone with combined ampicillin and gentamicin therapy for patients with cholangitis. Arch Intern Med 1989;49(6):1279-84.
57. Davis AJ, Kolios G, Alveyn CG, Robertson DA. Antibiotic prophylaxis for ERCP: A comparison of oral ciprofloxacin with intravenous cephazolin in the prophylaxis of high-risk patients. Aliment Pharmacol Ther 1998;12(3):207-11.
58. Westphal JF, Brogard JM. Biliary Tract Infections: a guide to drug treatment. Drugs 1999;57:81-91.
59. Greff M. Guidelines of the French Society of Digestive Endoscopy (SFED): Antibiotic prophylaxis in digestive endoscopy. Endoscopy 1998;30(9):873-5.
60. Devière J, Baize M, de Toeuf J, Cremer M. Long-term follow up of patients with hilar strictures treated by endoscopic internal biliary drainage. Gastrointest Endosc 1988;34:95-101.
61. Chang W-H, Kortan P, Haber GB. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc 1998;47:354-62.
62. Hintze RE, Abou-Rebyeh H, Adler A, Veltzke-Schlieker W, Felix R, Wiedenmann B. Magnetic resonance cholangiopancreaticography-guided unilateral endoscopic stent placement for Klatskin tumors. Gastrointest Endosc 2001;53:40-6.